| 1 |
Wang T, Xu P, Fang J, Li C, Zeng X, Liu J, Meng L, Zhuang R, Zhang X, Su X, Guo Z. Synthesis and Preclinical Evaluation of a (68)Ga-Labeled Pyridine-Based Benzamide Dimer for Malignant Melanoma Imaging. Mol Pharm 2023;20:1015-24. [PMID: 36562303 DOI: 10.1021/acs.molpharmaceut.2c00745] [Reference Citation Analysis]
|
| 2 |
Carlsen EA, Loft M, Loft A, Czyzewska D, Andreassen M, Langer SW, Knigge U, Kjaer A. Prospective Phase II Trial of [(68)Ga]Ga-NODAGA-E[c(RGDyK)](2) PET/CT Imaging of Integrin α(v)β(3) for Prognostication in Patients with Neuroendocrine Neoplasms. J Nucl Med 2023;64:252-9. [PMID: 35981899 DOI: 10.2967/jnumed.122.264383] [Reference Citation Analysis]
|
| 3 |
Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, Citro A, Ferrara B, Policardi M, Valtorta S, Pocaterra A, Alfano M, Sheppard D, Piemonti L, Moresco RM, Corti A, Curnis F. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins. Int J Biol Sci 2023;19:156-66. [PMID: 36594095 DOI: 10.7150/ijbs.76148] [Reference Citation Analysis]
|
| 4 |
Zhang W, Ye J, Li X, Li Y, Feng G. Integrin α6 targeted cancer imaging and therapy. Vis Cancer Med 2023;4:4. [DOI: 10.1051/vcm/2022007] [Reference Citation Analysis]
|
| 5 |
Notni J. RGD Forever!-Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences. Pharmaceuticals (Basel) 2022;16. [PMID: 36678553 DOI: 10.3390/ph16010056] [Reference Citation Analysis]
|
| 6 |
Roesch F, Martin M. Radiometal-theranostics: the first 20 years*. J Radioanal Nucl Chem 2022. [DOI: 10.1007/s10967-022-08624-3] [Reference Citation Analysis]
|
| 7 |
Khodadust F, Ezdoglian A, Steinz MM, van Beijnum JR, Zwezerijnen GJC, Jansen G, Tas SW, van der Laken CJ. Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis. IJMS 2022;23:7071. [DOI: 10.3390/ijms23137071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
van der Geest KSM, Sandovici M, Nienhuis PH, Slart RHJA, Heeringa P, Brouwer E, Jiemy WF. Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica. Front Med 2022;9:902155. [DOI: 10.3389/fmed.2022.902155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Dietz M, Kamani CH, Dunet V, Fournier S, Rubimbura V, Testart Dardel N, Schaefer A, Jreige M, Boughdad S, Nicod Lalonde M, Schaefer N, Mewton N, Prior JO, Treglia G. Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review. Front Med 2022;9:887508. [DOI: 10.3389/fmed.2022.887508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Kossatz S, Beer AJ, Notni J. It's Time to Shift the Paradigm: Translation and Clinical Application of Non-αvβ3 Integrin Targeting Radiopharmaceuticals. Cancers (Basel) 2021;13:5958. [PMID: 34885066 DOI: 10.3390/cancers13235958] [Reference Citation Analysis]
|
